Literature DB >> 852752

Glucosamine synthetase activity of the colonic mucosa in ulcerative colitis and Crohn's disease.

M J Goodman, P W Kent, S C Truelove.   

Abstract

Glucosamine synthetase is the first enzyme in glycoprotein biosynthesis, catalysing the formation of glucosamine-6-phosphate, from which N-acetylglucosamine is formed. The levels of this enzyme in normal human colonic mucosa (in colectomy specimens and rectal biopsies) were found to be 13-8 +/- 4-0 micron mol glucosamine synthesised/h/g wet wt. In the colonic mucosa in ulcerative colitis and Crohn's colitis the enzyme level was diminished when there was loss of epithelial cells in the mucosa, although not when there was just loss of goblet cells. In patients recovering from an acute attack of ulcerative colitis, the enzyme levels rose to a peak above the normal range, an effect which did not occur in patients who did not recover promptly. This recovery peak may be related to the synthesis of gastrointestinal mucus, or immunoglobulin, or the secretory component of IgA, all of which contain large amounts of N-acetylglucosamine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 852752      PMCID: PMC1411386          DOI: 10.1136/gut.18.3.219

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  THE FEEDBACK CONTROL OF SUGAR NUCLEOTIDE BIOSYNTHESIS IN LIVER.

Authors:  S KORNFELD; R KORNFELD; E F NEUFELD; P J O'BRIEN
Journal:  Proc Natl Acad Sci U S A       Date:  1964-08       Impact factor: 11.205

2.  A colorimetric method for the determination of N-acetylglucosamine and N-acetylchrondrosamine.

Authors:  W T Morgan; L A Elson
Journal:  Biochem J       Date:  1934       Impact factor: 3.857

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Glucosamine 6-phosphate synthesis in normal and neoplastic rat tissues.

Authors:  M Kaufman; M C Yip; W E Knox
Journal:  Enzyme       Date:  1971

5.  Purification and some kinetic properties of rat liver glucosamine synthetase.

Authors:  P J Winterburn; C F Phelps
Journal:  Biochem J       Date:  1971-02       Impact factor: 3.857

6.  The use of isolated cells to assess the contribution of the mucosal epithelium to the metabolism of the intestinal wall.

Authors:  E M Evans; K Burdett
Journal:  Gut       Date:  1973-02       Impact factor: 23.059

7.  Regulation of glucosamine synthesis in injury and partial hepatectomy.

Authors:  R L Bley; H Okubo; A M Chandler
Journal:  Proc Soc Exp Biol Med       Date:  1973-10-01

8.  Formation of glucosamine 6-phosphate in regenerating rat liver.

Authors:  N Akamatsu; H R Maeda
Journal:  Biochim Biophys Acta       Date:  1971-08-19

9.  Origin and renewal of goblet cells in the epithelium of the mouse small intestine.

Authors:  J Merzel; C P Leblond
Journal:  Am J Anat       Date:  1969-03

10.  L-glutamine:D-fructose 6-phosphate amidotransferase in tumors and the liver of tumor-bearing animals.

Authors:  H Kikuchi; Y Kobayashi; S Tsuiki
Journal:  Biochim Biophys Acta       Date:  1971-06-22
View more
  13 in total

1.  Prolyl hydroxylase activity in serum and rectal mucosa in inflammatory bowel disease.

Authors:  M F Farthing; A P Dick; G Heslop; C I Levene
Journal:  Gut       Date:  1978-08       Impact factor: 23.059

2.  In vivo analysis of mucosal lipids reveals histological disease activity in ulcerative colitis using endoscope-coupled Raman spectroscopy.

Authors:  Hao Ding; Andrew W Dupont; Shashideep Singhal; Larry D Scott; Sushovan Guha; Mamoun Younes; Xiaohong Bi
Journal:  Biomed Opt Express       Date:  2017-06-23       Impact factor: 3.732

3.  Faecal diversion for Crohn's colitis: a model to study the role of the faecal stream in the inflammatory process.

Authors:  M C Winslet; A Allan; V Poxon; D Youngs; M R Keighley
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

4.  Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis.

Authors:  R D Pullan; G A Thomas; M Rhodes; R G Newcombe; G T Williams; A Allen; J Rhodes
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

5.  Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease.

Authors:  C O'Morain; A E Bishop; G P McGregor; A J Levi; S R Bloom; J M Polak; T J Peters
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

6.  Mucosal enzyme activity for butyrate oxidation; no defect in patients with ulcerative colitis.

Authors:  E S Allan; S Winter; A M Light; A Allan
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

7.  Glycosylation and sulphation of colonic mucus glycoproteins in patients with ulcerative colitis and in healthy subjects.

Authors:  H Morita; M G Kettlewell; D P Jewell; P W Kent
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

8.  Biochemical analysis of enzymic markers of inflammation in rectal biopsies from patients with ulcerative colitis and Crohn's disease.

Authors:  C O'Morain; P Smethurst; A J Levi; T J Peters
Journal:  J Clin Pathol       Date:  1983-11       Impact factor: 3.411

9.  Mucosal glucosamine synthetase activity in inflammatory bowel disease.

Authors:  M C Winslet; V Poxon; A Allan; M R Keighley
Journal:  Dig Dis Sci       Date:  1994-03       Impact factor: 3.199

10.  Regional distribution and alterations of lectin binding to colorectal mucin in mucosal biopsies from controls and subjects with inflammatory bowel diseases.

Authors:  L R Jacobs; P W Huber
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.